Evaluate the Safety of DEXYCU for the Treatment of Inflammation Following Ocular Surgery for Childhood Cataract

Inclusion Criteria:

• Undergoing uncomplicated cataract surgery with or without a posterior chamberintraocular lens (IOL) implantation.

• If a contact lens is used for correction of post-operative aphakia, it must be asilicone elastomer lens or a rigid gas permeable lens (no water content).

• Other protocol-specified inclusion criteria may apply.

Exclusion Criteria:

• Presence of clinically significant gastrointestinal, cardiovascular, hepatic, renal,hematological, endocrine, neurological, psychiatric, respiratory, or other medicalcondition that could increase the risk to the subject as determined by theinvestigator.

• Has a post-traumatic cataract.

• Presence of active or suspected viral, bacterial, or fungal disease in the studyeye.

• Ocular hypertension with an IOP in the study eye >25 mmHg at Screening with orwithout treatment with anti-glaucoma monotherapy.

• Subjects who have received a periocular corticosteroid injection in the study eye inthe 3 months prior to Screening.

• Subjects who have received any intravitreal corticosteroid delivery vehicle (eg,Retisert®, Ozurdex®, Iluvien®) in the study eye at any time.

• Other protocol-specified exclusion criteria may apply